You must enable scripting on your browser to be able to use all the functionality of the site
Contact Us
|
Site Index
|
FMCSA
|
FMCSA Portal
|
DOT.gov
Home
Conferences
Training and Testing
Medical Examiners
Drivers and Carriers
Rules and Regs
FMCSA Medical Examiner Handbook Map
FMCSA Medical Examiner Handbook - Home Page
Part I - General FMCSA Information
FMCSA Mission Statement
FMCSA: Dedicated to Safety
Who Can Be a Medical Examiner?
When Is Medical Certification Required?
Important Definitions
Privacy and the Medical Examination
Medical Regulations Summary
Part II - The Job of Commercial Driving
FMCSA Regulates Interstate Commercial Operation
The Driver and Driver Role
FMCSA Commercial Driving Facts and Research
Part III - Medical Examination Guidelines
About 49 CFR 391.43
Driver/Medical Examiner Relationship
Medical Examination Report Form - Overview
Medical Examination Report Form (PDF)
Driver Information
Health History
Vision
Hearing
Blood Pressure/Pulse
Urinalysis
Physical Examination
Determine Certification Status
Certify
Disqualify
Issue Medical Examiner's Certificate
Part IV - Physical Qualification Standards
Part IV - Guidance/Advisory Criteria
About 49 CFR 391.41
Vision 49 CFR 391.41(b)(10)
Ophthalmic Preparations
Vision Tests
Ophthalmic Diseases
Federal Vision Exemption Program
Hearing 49 CFR 391.41(b)(11)
Otic Preparations
Hearing Tests
Otic Disease and Conditions
Hypertension (b)(6)
Measure Blood Pressure & Check Pulse
Essential Hypertension
Stage 1 Hypertension
Stage 2 Hypertension
Stage 3 Hypertension
Secondary Hypertension
Cardiovascular (b)(4)
Anticoagulant Therapy (content links)
Cardiovascular Tables Archive
Aneurysms, Peripheral Vascular Disease, and Venous Disease and Treatments
Abdominal Aortic Aneurysm
Acute Deep Vein Thrombosis
Chronic Thrombotic Venous Disease
Intermittent Claudication
Other Aneurysms
Peripheral Vascular Disease
Post-Surgical Repair of Aneurysm
Pulmonary Emboli
Superficial Phlebitis
Thoracic Aneurysm
Varicose Veins
Cardiac Arrhythmias and Treatments
Implantable Cardioverter-Defibrillators
Pacemakers
Supraventricular Arrhythmias
Ventricular Arrhythmias
Cardiovascular Tests
Echocardiography
Exercise Tolerance Test
Cardiovascular Recommendation Tables Only — Available in PDF
Coronary Heart Diseases and Treatments
Acute Myocardial Infarction
Angina Pectoris
CHD Risk-Equivalent — Multiple CHD Risk Factors
Coronary Artery Bypass Grafting
Heart Failure
Percutaneous Coronary Intervention
Congenital Heart Disease
Ebstein Anomaly
Heart Transplantation
Hypertension (b)(6)
Measure Blood Pressure & Check Pulse
Essential Hypertension
Stage 1 Hypertension
Stage 2 Hypertension
Stage 3 Hypertension
Secondary Hypertension
Myocardial Disease
Hypertrophic Cardiomyopathy
Restrictive Cardiomyopathy
Syncope
Valvular Heart Diseases and Treatments
Aortic Regurgitation
Aortic Stenosis
Aortic Valve Repair
Mitral Regurgitation
Mitral Stenosis
Mitral Stenosis Treatment
Mitral Valve Prolapse
Mitral Valve Repair for Mitral Regurgitation
Prosthetic Valves
Pulmonary Valve Stenosis
Respiratory (b)(5)
Antihistamine Therapy
Allergies and Asthma-related Diseases
Allergic Rhinitis
Allergy-related Life-threatening Conditions
Asthma
Hypersensitivity Pneumonitis
Chronic Obstructive Pulmonary Disease
Chronic Sleep Disorders
Infectious Respiratory Diseases
Acute Infectious Diseases
Atypical Tuberculosis
Pulmonary Tuberculosis
Non-infectious Respiratory Diseases
Chest Wall Deformities
Chronic Obstructive Pulmonary Disease
Cystic Fibrosis
Interstitial Lung Disease
Pneumothorax
Pulmonary Function Tests
Secondary Respiratory Conditions and Underlying Disorders
Chronic Sleep Disorders
Cor Pulmonale
Pulmonary Hypertension
Sleep Disorder Tests
Neurological (b)(7)(8)(9)
Anticoagulant Therapy (content links)
Anticonvulsant Therapy
Episodic Neurological Conditions
Acute Seizures — Structural Insult to the Brain
Acute Seizures — Systemic Metabolic Illness
Childhood Febrile Seizures
Epilepsy
Headaches
Single Unprovoked Seizure
Vertigo and Dizziness
Infections of the Central Nervous System
Neuromuscular Diseases
Autonomic Neuropathy
Conditions Associated with Abnormal Muscle Activity
Congenital Myopathies
Metabolic Muscle Diseases
Motor Neuron Diseases
Muscular Dystrophies
Neuromuscular Junction Disorders
Peripheral Neuropathies
Progressive Neurological Conditions
Central Nervous System Tumors
Dementia
Static Neurological Conditions
Embolic and Thrombotic Strokes
Intracerebral and Subarachnoid Hemorrhages
Transient Ischemic Attack
Traumatic Brain Injury
Summary of Neurological Waiting Periods
Musculoskeletal (b)(1)(2)(7)
Skill Performance Evaluation — 49 CFR 391.49
Fixed Deficit of an Extremity
Musculoskeletal Tests
Grip Strength Tests
Neuromuscular Diseases
Autonomic Neuropathy
Conditions Associated with Abnormal Muscle Activity
Congenital Myopathies
Metabolic Muscle Diseases
Motor Neuron Diseases
Muscular Dystrophies
Neuromuscular Junction Disorders
Peripheral Neuropathies
Diabetes Mellitus (b)(3)
Diabetes Mellitus
Federal Diabetes Exemption Program
Incretin Mimetic
Insulin Therapy
Non-Insulin Medications
Other Diseases (b)(9)
Hernia
Nephropathy
Urinalysis
Psychological Disorders
(b)(9)
Antidepressant Therapy (content links)
Antipsychotic Therapy(content links)
Anxiolytic and Sedative Hypnotic Therapy (content links)
Central Nervous System Stimulant Therapy (content links)
Electroconvulsive Therapy (content links)
Lithium Therapy (content links)
Adult Attention Deficit Hyperactivity Disorder
Bipolar Mood Disorder
Major Depression
Personality Disorders
Schizophrenia and Related Psychotic Disorders
Drug Abuse and Alcoholism(b)(12)(13)
About 49 CFR 382 Alcohol and Drug Rules
Alcoholism
Drug Abuse
Medications/Drug Use 49 CFR 391.41(b)(12)
About 21 USC Sec. 812 Schedules of Controlled Substances
Medical Examination Report Form Summary
Medical Examination Report Form - Page 1
Medical Examination Report Form - Page 2
Medical Examination Report Form - Page 3
Handbook Map